Dr. Shannon Schmidt
Claim this profileThedaCare Regional Cancer Center
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
ThedaCare Regional Cancer Center
ThedaCare Regional Medical Center - Neenah
Clinical Trials Shannon Schmidt is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
More about Shannon Schmidt
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Shannon Schmidt has experience with
- Trastuzumab
- Pertuzumab
- Paclitaxel
- Trastuzumab Emtansine
- Tucatinib
- Olaparib
Breakdown of trials Shannon Schmidt has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shannon Schmidt specialize in?
Shannon Schmidt focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Shannon Schmidt currently recruiting for clinical trials?
Yes, Shannon Schmidt is currently recruiting for 4 clinical trials in Appleton Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Shannon Schmidt has studied deeply?
Yes, Shannon Schmidt has studied treatments such as Trastuzumab, Pertuzumab, Paclitaxel.
What is the best way to schedule an appointment with Shannon Schmidt?
Apply for one of the trials that Shannon Schmidt is conducting.
What is the office address of Shannon Schmidt?
The office of Shannon Schmidt is located at: ThedaCare Regional Cancer Center, Appleton, Wisconsin 54911 United States. This is the address for their practice at the ThedaCare Regional Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.